H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 94 Citations 40,700 303 World Ranking 4838 National Ranking 53

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

His scientific interests lie mostly in Cancer research, Gene expression, Cancer, Bladder cancer and Internal medicine. His work deals with themes such as DNA methylation, Carcinogenesis, Cancer cell, Cell cycle and Gene silencing, which intersect with Cancer research. His Gene expression study results in a more complete grasp of Gene.

His research in Cancer tackles topics such as microRNA which are related to areas like DNA microarray. His Bladder cancer research also works with subjects such as

  • Pathology which connect with Urothelium, Urinary bladder, Colorectal cancer and S100 Calcium Binding Protein A7,
  • Mutation together with Chromatin. He combines subjects such as Genetic model, Diabetes mellitus, Endocrinology and Oncology with his study of Internal medicine.

His most cited work include:

  • Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets (4665 citations)
  • DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis (2235 citations)
  • Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints (1500 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Cancer research, Pathology, Bladder cancer and Cancer. His Internal medicine study combines topics in areas such as Endocrinology and Oncology. Torben F. Ørntoft has included themes like Methylation, Carcinogenesis, Cancer cell, microRNA and Gene silencing in his Cancer research study.

The concepts of his Pathology study are interwoven with issues in Urothelium, Gene expression and Antigen. His Bladder cancer study deals with Urine intersecting with Urology and Cystoscopy. His biological study spans a wide range of topics, including Stage and Immunology.

He most often published in these fields:

  • Internal medicine (30.38%)
  • Cancer research (24.26%)
  • Pathology (24.26%)

What were the highlights of his more recent work (between 2015-2020)?

  • Internal medicine (30.38%)
  • Oncology (21.10%)
  • Prostate cancer (14.77%)

In recent papers he was focusing on the following fields of study:

Torben F. Ørntoft focuses on Internal medicine, Oncology, Prostate cancer, Cancer and Bladder cancer. His Oncology research is multidisciplinary, relying on both Bioinformatics, Disease, Cohort, Pathology and microRNA. His study in the field of Biopsy also crosses realms of Cell-free fetal DNA.

His Cancer research incorporates elements of Mutation and Gene. His Bladder cancer research includes themes of Exome sequencing, Progressive disease, Cancer research and Metastasis. The various areas that he examines in his Cancer research study include Regulation of gene expression and Gene silencing.

Between 2015 and 2020, his most popular works were:

  • Direct detection of early-stage cancers using circulating tumor DNA (420 citations)
  • Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma (269 citations)
  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (268 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Torben F. Ørntoft mainly investigates Bladder cancer, Internal medicine, Oncology, Disease and Cancer research. His studies in Bladder cancer integrate themes in fields like Mutation, Urine and Urology. His Oncology research is multidisciplinary, incorporating elements of Prostate cancer and Genetic association.

His Disease study is concerned with the field of Pathology as a whole. His Pathology study combines topics in areas such as Biomarker, Colorectal cancer and Digital polymerase chain reaction. He combines subjects such as Cancer, Bioinformatics, Transcriptome, microRNA and Gene silencing with his study of Cancer research.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets

Claus Lindbjerg Andersen;Jens Ledet Jensen;Torben Falck Ørntoft.
Cancer Research (2004)

7793 Citations

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

Jirina Bartkova;Zuzana Ho rcaron;ejší;Karen Koed.
Nature (2005)

2962 Citations

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

Jirina Bartkova;Nousin Rezaei;Michalis Liontos;Panagiotis Karakaidos.
Nature (2006)

1962 Citations

Genome-wide association study identifies five new schizophrenia loci

Stephan Ripke;Alan R. Sanders;Kenneth S. Kendler;Douglas F. Levinson.
Nature Genetics (2011)

1603 Citations

Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH.

Oliver M Sieber;Lara Lipton;Michael Crabtree;Karl Heinimann.
The New England Journal of Medicine (2003)

1037 Citations

Identifying distinct classes of bladder carcinoma using microarrays

Lars Dyrskjøt;Thomas Thykjaer;Mogens Kruhøffer;Jens Ledet Jensen.
Nature Genetics (2003)

682 Citations

Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer

Troels Schepeler;Jørgen T. Reinert;Marie S. Ostenfeld;Lise L. Christensen.
Cancer Research (2008)

581 Citations

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.

Lars Dyrskjøt;Mogens Kruhøffer;Thomas Thykjaer;Niels Marcussen.
Cancer Research (2004)

553 Citations

p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest

Christian J. Braun;Xin Zhang;Irina Savelyeva;Sonja Wolff.
Cancer Research (2008)

521 Citations

Direct detection of early-stage cancers using circulating tumor DNA

Jillian Phallen;Mark Sausen;Vilmos Adleff;Alessandro Leal.
Science Translational Medicine (2017)

494 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Torben F. Ørntoft

Decio L. Eizirik

Decio L. Eizirik

Université Libre de Bruxelles

Publications: 120

Ole A. Andreassen

Ole A. Andreassen

Oslo University Hospital

Publications: 112

Thomas Werge

Thomas Werge

University of Copenhagen

Publications: 103

Anders D. Børglum

Anders D. Børglum

Lundbeck (Denmark)

Publications: 102

Stephan Ripke

Stephan Ripke

Massachusetts General Hospital

Publications: 94

Ole Mors

Ole Mors

Aarhus University Hospital

Publications: 93

Audrey Goddard

Audrey Goddard

Genentech

Publications: 92

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 90

Vassilis G. Gorgoulis

Vassilis G. Gorgoulis

National and Kapodistrian University of Athens

Publications: 88

Rosalind A. Eeles

Rosalind A. Eeles

Institute of Cancer Research

Publications: 87

Patrick F. Sullivan

Patrick F. Sullivan

University of North Carolina at Chapel Hill

Publications: 84

Paul J. Godowski

Paul J. Godowski

Genentech

Publications: 84

David M. Hougaard

David M. Hougaard

Statens Serum Institut

Publications: 81

Preben Bo Mortensen

Preben Bo Mortensen

Aarhus University

Publications: 80

Jiri Bartek

Jiri Bartek

Science for Life Laboratory

Publications: 76

Something went wrong. Please try again later.